Top Pharma Investment: Novartis and Sandoz lead as the top foreign investors in Slovenia, strengthening its position as a prime destination for pharma industries. Get ready as Sandoz ramps up with a whopping €400 million investment in a new biosimilar drug production facility in Lendava. Meanwhile, Novartis continues to expand, pouring €245 million last year into enhancing its production facilities in Ljubljana and a state-of-the-art Biocampus in Mengeš. Slovenia is now Novartis’ largest global hub for biologic drug ingredients!
Other Key Investments in 2023: The investment wave continues with German luxury motorhome manufacturer Carthago, which invested €50 million in a new plant in Ormož, northeastern Slovenia. Not to be outdone, Goodyear pumped €94 million into expanding their Kranj facilities, further solidifying Slovenia’s role in global manufacturing.
Upcoming Investments: Keep an eye on BSH Home Appliances, which plans to construct an €80 million factory in Nazarje. Plus, German companies EBM Papst and Herz are set to build new plants, boosting Slovenia’s manufacturing capabilities in small electric motors and HVAC systems, respectively.
Strategic Acquisitions: In a move to embrace innovation, British Volution Group acquired a significant stake in iVent, a trailblazer in ventilating systems and one of Slovenia’s fastest-growing companies. Furthermore, FTA Šentjur has joined forces with Germany’s TQ Group, marking a significant merger in the electronics sector.
M&A Services by SIBIZ: At SIBIZ, we offer a full range of M&A services tailored for foreign direct investors looking to enter or expand in the Slovenian and regional CEE markets. For expert guidance and strategic partnership opportunities, reach out to us at [email protected] or call +386 1 200 92 00.
Slovenia is clearly on the rise as a dynamic hub for both innovation and investment. Keep watching this space for more updates on how these developments unfold! #InvestInSlovenia #BusinessGrowth #PharmaInvestments #InnovationHub #SIBIZMnAServices
